A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD
A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD
Recruiting · NCT07683065 · Registry updated 2026-08-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD | metabolic dysfunction-associated steatotic liver disease | Recruiting | Not stated | 2026-08-14 | NCT07683065 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Novartis Pharmaceuticals | 432 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||